Loss of chromosome 11 and 11 P/Q imbalances in bladder cancer detected by fluorescence in situ hybridization

International Journal of Cancer

Volumn 65, Issue 3, 1996, Pages 301-307

  Voorter, Christina E M ^a   Ummelen, Monique I J ^a   Ramaekers, Frans S C ^a   Hopman, Anton H N ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CHROMOSOME 11; CHROMOSOME LOSS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

CHROMOSOMES, HUMAN, PAIR 11; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION; PLOIDIES; URINARY BLADDER NEOPLASMS;

EID: 0030026145     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960126)65:3<301::AID-IJC4>3.0.CO;2-3     Document Type: Article

References (33)

1. CALL, K.M., GLASER, T., ITO, C.Y., BUCKLER, A.J., PELLETIER, J., HABER, D.A., ROSE, E.A., KRAL, A., YEGER, H., LEWIS, W.H., JONES, C. and HOUSMAN, D.E., Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60, 509-520 (1990).
2. DALBAGNI, G., PRESTI, J., REUTER, V., FAIR, W.R. and CORDON-CARDO, C., Genetic alterations in bladder cancer. Lancet, 342, 469-471 (1993).
3. FEARON, E.R., FEINBERG, A.P., HAMILTON, S.H. and VOGELSTEIN, B., Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature (Lond.), 318, 377-380 (1985).
4. FUJIMORI, M., TOKINO, T., HINO, O., KOTAGAWA, T., IMAMURA, T., OKAMOTO, E., MITSUNOBY, M., ISHIKAWA, T., NAKAGAMA. H., HARADA, H., YAGURA, M., MATSUBARA, K. and NAKAMURA, Y., Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51, 89-93 (1991).
5. GESSLER, M., POUSTKA, A., CAVENEE, W., NEVE, R.L., ORKIN, S.H. and BRUNS, G.A.P., Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343, 774-778 (1990).
6. GIBAS, Z., PROUT, G.R., PONTES, J.E., CONNOLLY, J.G. and SANDBERG, A.A., A possible specific chromosome change in transitional-cell carcinoma of the bladder. Cancer Genet. Cytogenet., 19, 229-238 (1986).
7. HOPMAN, A.H., MOESKER, O., SMEETS, A.W., PAUWELS, R.P., VOOIJS, G.P. and RAMAEKERS, F.C., Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res., 51, 644-651 (1991a).
8. HOPMAN, A.H., PODDIGHE, P.J., SMEETS, A.W., MOESKER, O., BECK, J.L., VOOJIS, G.P. and RAMAEKERS, F.C., Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Amer. J. Pathol., 135, 1105-1117 (1989).
9. HOPMAN, A.H., VAN HOOREN, E., VAN DE KAA, CA., VOOJIS, P.G. and RAMAEKERS, F.C., Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod. Pathol. 4, 503-513 (1991b).
10. KALLIONIEMI, A., KALLIONIEMI, O.-P., CITRO, G., SAUTER, G., DEVRIES, S., KERSCHMANN, R., CAROLL, P. and WALDMAN, F., Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chrom. Cancer, 12, 213-219 (1995).
11. KNOWLES, M.A., ELDER, P.A., WILLIAMSON, M., CAIRNS, J.P., SHAW, M.E. and LAW, M.G., Allelotype of human bladder cancer. Cancer Res., 54, 531-538 (1994).
12. LUDWIG, C.U., RAEFLE, G., DALQUEN, P., STULZ, P., STAHEL, R. and OBRECHT, J.-P., Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer. Int. J. Cancer, 49, 661-665 (1991).
13. NEDERLOF, P.M., ROBINSON, D., ABUKNESHA, R., WIEGANT, J., HOPMAN, A.H., TANKE, H.J. and RAAP, A.K., Three-color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequences. Cytometry, 10, 20-27 (1989).
14. NEGRINI, M., SABBIONI, S., POSSATI, L., RATTAN, S., CORALLINI, A., BRABANTI-BRODANO, G. and CROCE, C.M., Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res., 54, 1331-1336 (1994).
15. OLUMI, A.F., TSAI, Y.C., NICHOLS, P.W., SKINNER, D.G., CAIN, D.R., BENDER, L.I. and JONES. P.A., Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50, 7081-7083 (1990).
16. PAUWELS, R.P., SMEETS, W.W., GERAEDTS, J.P. and DEBRUYNE, F.M., Cytogenetic analysis in urothelial cell carcinoma. J. Urol., 137, 210-215 (1987).
17. PODDIGHE, P.J., RAMAEKERS, F.C., SMEETS, A.W., Voous, G.P. and HOPMAN, A.H., Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe. Cancer Res., 52, 4929-4934 (1992).
18. PRESTI, J.C., REUTER, V.E., GALAN, T., FAIR, W.R. and CORDON-CARDO, C., Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res., 51, 5405-5409 (1991).
19. REZNIKOFF, C.A., KAO, C.H., MESSING, E.M., NEWTON, M. and SWAMINATHAN, S., A molecular genetic model of human bladder carcinogenesis. Sem. Cancer Biol., 4, 143-152 (1993).
20. SABBIONI, S., NEGRINI, M., POSSATI, L., BONFATTI, A., CORALLINI, A., SENSI, A., STANBRIDGE, E.J. and BARBANTI-BRODANO, G., Multiple loci on human chromosome 11 control tumorigenicity of BK-virus-transformed cells. Int. J. Cancer, 57, 185-191 (1994).
21. SANDBERG, A.A. and BERGER, C.S., Review of chromosome studies in uroloaical tumors. II. Cytogenetics and molecular genetics of bladder cancer. J. Urol., 151, 545-560 (1994).
22. SAUTER, G., DENG, G., MOCH, H., KERSCHMANN, R., MATSUMURA, K., VRIES, S.D., GEORGE, T., FUENTES, J., CARROLL, P., MIHATSCH, M.J. and WALDMAN, F.M., Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Amer. J. Pathol. 144, 756-766 (1994).
23. SCRABLE, H.J., WITTE, D.P., LAMPKIN, B.C. and CAVENEE, W.K., Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature (Lond.). 329, 645-647 (1987).
24. SHAW, M.E. and KNOWLES, M.A., Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chrom. Cancer, 13, 1-8 (1995).
25. SHIPMAN, R., SCHRAML, P., COLOMBI, M., RAEFLE, G. and LUDWIG, C.U., Loss of heterozygosity on chromosome-11P13 in primary bladder carcinoma. Hum. Genet., 91, 455-458 (1993).
26. SPRUCK, C.H., OHNESEIT, P.P., GONZALEZ-ZULUETA, M., ESRIG, D., MIYAO, N., TSAI, Y.C., LERNER, S.P., SCHMUTTE, C., YANG, A.S., COTE, R., DUBEAU, L., NICHOLS, P.W., HERMANN, G.G., STEVEN, K., HORN, T., SKINNER, D.G. and JONES, P.A., Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54, 784-788 (1994).
27. TOKINO, T., TAKAHASHI, E., MORI, M., TANIGAMIN, A., GLASER, T., PARK, J.W., JONES, C., HORI, T. and NAKAMURA, Y., Isolation and mapping of 62 new RFLP markers on human chromosome 11. Amer. J. Hum. Genet., 48, 258-268 (1991).
28. TRIBUKAIT, B., Tumor biology in diagnostic cytology: DNA cytometry in carcinomas of the bladder and prostate. Rec. Results Cancer Res., 133, 23-31 (1993).
29. VIEL, A., GIANNINI, F., TUMIOTTO, L., SOPRACORDEVOLE, F., VISENTIN, M.C. and BOIOCCHI, M., Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Brit. J. Cancer, 66, 1030-1036 (1992).
30. VOORTER, C., JOOS, S., BRINGUIER, P.-P., VALLINGA, M., PODDIGHE, P., SCHALKEN, J., MANOIR, S.D., RAMAEKERS, F., LICHTER, P. and HOPMAN, A., Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Amer. J. Pathol., 146, 1341-1354 (1995).
31. WALDMAN, P.M., CARROLL, P.R., KERSCHMANN, R., COHEN, M.B., FIELD. F.G. and MAVALL, B.H., Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 51, 3807-3813 (1991).
32. WAYE, J.S. and WILLARD, H.F., Chromosome specificity of satellite DNAs: short- and long-range organization of a diverged dimeric subset of human alpha satellite from chromosome 3. Chromosoma, 97, 475-480 (1989).
33. WHEELESS, L.L., BADALAMENT, R.A., WHITE, R.W.D., FRADET, Y. and TRIBUKAIT, B., Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry, 14, 478-481 (1993).